NIDA supported the participation of two U.S. researchers at a November 23–27, 2010, meeting in Mexico City on the Basic Parent Management Training-Oregon (PMTO) Model. The meeting was organized by Dr. Maria Elena Medina-Mora Icaza, Mexican National Institute of Psychiatry, “Dr. Ramón de la Fuente Múñiz,” to advance the binational research project, Development and Implementation of a Training Model in Positive Parenting Practices in Mexican Families With Children Who Present Behavior Problems.
Steffanie A. Strathdee, Ph.D.
Department of Medicine
University of California San Diego School of Medicine
San Diego, California, United States and
María Remedios Lozada Romero, M.D.
Baja California State
Tijuana, Mexico and
Carlos Magis-Rodríguez, M.D., M.P.H.
Department of Research
Mexico City, Mexico
The Red Latinamericano de Investigaciones en Drogas (known commonly as REDLA) is making an impact on the sphere of drug abuse and addiction research in Latin America.
A network of academic researchers who share an interest in developing research on the drug problem in Latin America, REDLA is a joint effort between NIDA and the Organization of American States, through their Inter-American Drug Control Commission (CICAD), with the collaboration of the National Hispanic Science Network on Drug Abuse.
A new fellowship program will enable talented Mexican postdoctoral scientists to devote 12 months to drug abuse prevention research in the United States.
NIDA and the Mexican National Institute of Psychiatry Ramón de la Fuente Muñiz (NIP), along with the Mexican National Commission Against Addictions (CONADIC) and the Society for Prevention Research, have established the United States–Mexico Drug Abuse Prevention Research Fellowship.
The NIDA International Program supported three participants in a Regional Grant Writing and Scientific Peer Review Workshop that was held June 27–29, 2012, in Bogotá, Colombia. The workshop, which was organized by U.S. and Latin American officials, provided guidance on identifying training and funding opportunities, developing grant applications, establishing collaborations, and understanding the grant review process, confidentiality, and conflict of interest. Ivan Montoya, M.D., NIDA Division of Pharmacotherapies and Medical Consequences of Addiction, was one of the U.S.
The United States and Mexico have issued a joint declaration (PDF, 43.8KB) of cooperation on drug demand reduction efforts that underscores a commitment to reduce illicit drug consumption and the need to work collaboratively with each other and additional partners in the region. The joint declaration was issued at the conclusion of the 8th U.S.–Mexico Bi-National Drug Demand Reduction Policy Meeting, which was held at the U.S.
INVEST-Clinical Trials Network (CTN) Fellow Mario Zapata, M.D., M.Sc., focused primarily on brief strategic family therapy and ended his fellowship year by submitting a grant application to fund a pilot project testing the effectiveness of the brief strategic family therapy protocol in Colombia. Working at the CTN Florida Node at the University of Miami, Dr.